search
Back to results

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

Primary Purpose

Hypertension

Status
Completed
Phase
Phase 4
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Valsaltan, amlodipine
Sponsored by
Yonsei University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring Non-dipper HTN patient

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Essential hypertension (stage 1-2)
  2. 24hr. holer : non-dipper
  3. Age 18 ~70.

Exclusion Criteria:

  1. Any known malignant disease
  2. Renal failure , creatinine >2.0mg/dl
  3. Liver disease

Sites / Locations

  • Severance Hospital, Yonsei University College of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

morning administration group

nocturnal administration group

Arm Description

Outcomes

Primary Outcome Measures

IMT(intima media thickness) Measure data(Sono)
IMT(intima media thickness) Measure data(Sono)

Secondary Outcome Measures

Full Information

First Posted
March 23, 2010
Last Updated
October 7, 2010
Sponsor
Yonsei University
search

1. Study Identification

Unique Protocol Identification Number
NCT01091753
Brief Title
Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers
Official Title
Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers
Study Type
Interventional

2. Study Status

Record Verification Date
October 2010
Overall Recruitment Status
Completed
Study Start Date
March 2008 (undefined)
Primary Completion Date
May 2009 (Actual)
Study Completion Date
September 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Yonsei University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the effect of nocturnal administration of Anti-hypertensive medications in Non-dippers. Efficacy variables. ECHO 24hr. horter IMT BUN/crea, urine analysis (microalbulinuria Cardio vascular event. "

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Non-dipper HTN patient

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
morning administration group
Arm Type
Placebo Comparator
Arm Title
nocturnal administration group
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Valsaltan, amlodipine
Intervention Description
nti hypertensive medication time (nocturnal administration vs morning administration
Primary Outcome Measure Information:
Title
IMT(intima media thickness) Measure data(Sono)
Time Frame
baseline
Title
IMT(intima media thickness) Measure data(Sono)
Time Frame
36 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Essential hypertension (stage 1-2) 24hr. holer : non-dipper Age 18 ~70. Exclusion Criteria: Any known malignant disease Renal failure , creatinine >2.0mg/dl Liver disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dong hun Choi
Organizational Affiliation
professor of division of Cardiology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Severance Hospital, Yonsei University College of Medicine
City
Seoul
Country
Korea, Republic of

12. IPD Sharing Statement

Learn more about this trial

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

We'll reach out to this number within 24 hrs